Total Liabilities: The total value of all possible claims against the corporation.
TScan Therapeutics, Inc. (TCRX) had Total Liabilities of $105.67M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$10.32M |
|
$-129.77M |
|
-- |
|
$10.32M |
|
$146.14M |
|
$-135.81M |
|
$6.05M |
|
$-129.77M |
|
$-129.77M |
|
$-129.77M |
|
$-129.77M |
|
$-129.77M |
|
$-129.77M |
|
$-135.81M |
|
$-132.95M |
|
129.78M |
|
129.78M |
|
$-1.00 |
|
$-1.00 |
|
| Balance Sheet Financials | |
$157.21M |
|
$8.71M |
|
$71.58M |
|
$228.79M |
|
$18.70M |
|
$32.53M |
|
$86.97M |
|
|
Total Liabilities |
$105.67M |
$123.12M |
|
$123.12M |
|
$123.12M |
|
56.90M |
|
| Cash Flow Statement Financials | |
$-135.32M |
|
$109.37M |
|
$-0.34M |
|
$183.72M |
|
$157.44M |
|
$-26.28M |
|
$11.71M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.41 |
|
-- |
|
-- |
|
0.21 |
|
0.26 |
|
100.00% |
|
-1315.38% |
|
-1315.38% |
|
-1287.62% |
|
-1256.81% |
|
-1256.81% |
|
$-139.73M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
-- |
|
-- |
|
-105.40% |
|
-105.40% |
|
-56.72% |
|
-83.37% |
|
$2.16 |
|
$-1.08 |
|
$-1.04 |
|